Ascendis Pharma (ASND) PT Raised to $332 at Stifel
Tweet Send to a Friend
Stifel analyst Alex Thompson raised the price target on Ascendis Pharma (NASDAQ: ASND) to $332.00 (from $325.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
